BABICH JOHN W,ZIMMERMAN CRAIG,JOYAL JOHN,LU GENLIANG
申请号：
PL14738117
公开号：
PL2943227T3
申请日:
2014.01.10
申请国别(地区):
PL
年份:
2018
代理人:
摘要：
Compounds according to Formula I and Formula II are potent inhibitors of PSMA. or Pharmaceutical compositions may include a complex of a radionuclide and a Formula I compound or a Formula II compound. Methods include using the radionuclide complex of a Formula I compound or a Formula II compound for treating or diagnosis of a disease or a condition associated with PSMA activity.
